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Abstract
Background: We tested the hypothesis that in patients with occlusion of the terminal internal carotid artery and/or
the proximal middle cerebral artery, a diffusion abnormality of 70 ml or less is accompanied by a diffusion/perfusion
mismatch of at least 100%.
Methods: Sixty-eight consecutive patients with terminal ICA and/or proximal MCA occlusions and who underwent
diffusion/perfusion MRI within 24 hours of stroke onset were retrospectively identified. DWI and mean transit time
(MTT) volumes were measured. Prospectively, 48 consecutive patients were identified with the same inclusion
criteria. DWI and time to peak (TTP) lesion volumes were measured. A large mismatch volume was defined as an
MTT or TTP abnormality at least twice the DWI lesion volume.
Results: In the retrospective study, 49 of 68 patients had a DWI lesion volume ≤ 70 ml (mean 20.2 ml; SEM 2.9 ml).
A DWI/MTT mismatch of > 100% was observed in all 49 patients (P< .0001). In the prospective study, there were
35/48 patients with DWI volumes ≤ 70 ml (mean 18.7 ml; SEM 3.0 ml). A mismatch > 100% was present in all 35
(P< .0001).
Conclusions: Acute stroke patients with major anterior circulation artery occlusion are exceedingly likely to have a
major diffusion/perfusion mismatch if the diffusion lesion volume is 70 ml or less. This suggests that
physiology-based patient assessments may be made using only vessel imaging and diffusion MRI as a simple
alternative to perfusion imaging.
Background
Patients with a major ischemic stroke syndrome due to
an occlusion of a major anterior circulation artery con-
stitute an important subset of stroke patients. They
commonly have severe neurological deficits and are at
high risk of having a poor outcome such as death or
dependent life. This is because occlusions of the ter-
minal internal carotid artery (ICA) and/or the middle
cerebral artery (MCA) interrupt blood flow to the MCA
territory, which comprises a large proportion of the
cerebral hemisphere that includes much eloquent cortex.
The blood flow physiology in this type of stroke has
interesting properties due to the collateral circulation
provided by pial collaterals from the ipsilateral anterior
and posterior cerebral arteries. A robust collateral circu-
lation can preserve a large portion of the MCA territory
for long periods. The collateral circulation also makes
infarct ‘core’ and the underperfused ‘penumbra’ in the
MCA territory dependent variables; if one is small, the
other must be large, and vice versa. The presence of a
small ‘core’ and large ‘penumbra’ raises the possibility of
treatment.
Reperfusion is a possible therapy, but it is necessary to
rapidly assess whether successful reperfusion will help the
patient significantly or whether the infarct is already too
large to make a clinical difference. The diffusion/perfusion
mismatch has been suggested as guide for this purpose,
but it remains controversial [1,2]. All agree that patients
with small regions of infarction and large areas of poorly
perfused brain tissue are likely to benefit from reperfusion
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farcted poorly perfused brain are poor candidates.
Problems however lie with detection of this informa-
tion. DWI is accepted as a very good (but not perfect)
measure of infarction (Class I, level of evidence A) [3].
Perfusion imaging is more problematic. It is difficult to
quantify [3-5]. In patients various parameters – time to
peak, mean transit time, area under the curve, etc. – differ
[5,6]. Some regions within the underperfused region are
severely threatened while decreased perfusion in other
areas is minor and readily reversible. The contrast used
during perfusion imaging has risks [7]. The procedure
prolongs the imaging and it takes time for the results of
the analysis of the data to be delivered to the treating
physicians. In contrast DWI results are immediately
available and relatively simple to interpret.
Because of the properties of the collateral circulation,
we hypothesized that, in patients with occlusions of the
distal ICA and/or mainstem MCA, the volume of DWI
abnormality would be inversely related to the volume of
decreased perfusion. Those patients with large DWI
lesions would have small residual areas of non-infarcted
but underperfused tissue, and those patients with small
DWI lesions would have relatively large regions of still
at-risk tissue. If this proves correct then MRI with DWI
imaging along with MRA or CTA of the supply arteries
would prove sufficient for decisions regarding reperfu-
sion. In this study we used a DWI lesion volume of
70 ml as the cut-off.
Methods
Patient selection
This study consisted of retrospective and prospective
components. Both components were compliant with the
Health Insurance Portability and Accountability Act
(HIPAA) and were approved by our institutional review
board (IRB).
The retrospective study utilized data from a published
study by Copen et al. [8], which demonstrated that a
clinically significant diffusion/perfusion mismatch is
common among acute ischemic stroke patients imaged
within 24 hours of stroke onset, and most commonly
occurs in patients with a proximal artery occlusion. In
that study, all patients who presented to the emergency
department (ED) of our hospital from June 2005 through
December 2006 with symptoms suggesting an acute
stroke syndrome were screened. Inclusion criteria for
the present analysis were:
1. MR imaging including DWI scan demonstrating an
acute anterior circulation infarct and perfusion-
weighted imaging.
2. CT angiography (CTA) or MR angiography (MRA)
of the head demonstrating a proximal anterior
circulation artery occlusion (i.e. terminal ICA and/or
proximal MCA).
3. All imaging was performed before any thrombolytic
therapies and within 24 hours of symptom onset.
In the second study, we prospectively identified
patients who presented to our hospital ED with stroke
symptoms in 2008. Patients were included in this study
if they met the same criteria as in the retrospective
study. Patients who received intravenous thrombolytic
prior to imaging were included if their imaging demon-
strated a diffusion/perfusion mismatch consistent with
persistent occlusion.
Imaging acquisition
All imaging studies were requested by ED physicians
based on clinical need and were not influenced by these
studies.
Computed tomography angiography
In the retrospective study, CTA was performed from the
C6 vertebral body level through the circle of Willis fol-
lowing injection of 100–140 ml of Isovue 61.2 g/100 mL
(Bracco Diagnostics, Princeton, NJ) at a rate of 3 ml/s.
Imaging was triggered 25 seconds after contrast material
injection (40 seconds for patients with atrial fibrillation).
Immediately afterward, a second set of images was
obtained from the aortic arch to the skull base. The
parameters were 2.5-mm slice thickness, 1.25-mm re-
construction interval, 140 kV, 220–250 mA, and 0.75:1
pitch.
In the prospective study, CT angiography was per-
formed from the vertex to the aortic arch following in-
jection of 80–120 ml of Isovue 370 (Bracco Diagnostics,
Princeton, NJ) at a rate of 3.5 ml/s. SmartPrep (GE Med-
ical Systems) was used with a region of interest 1 cm
below the carina covering the entire lumen of the
ascending aorta. Scanning began with a 10-second delay
after the region of interest reached 75 HU. The para-
meters were 1.25-mm slice thickness, 0.625-mm recon-
struction interval, 120 kV, 350–800 mA, and 0.516:1
pitch.
Magnetic resonance imaging
MR imaging was performed on a 1.5 T Signa whole body
scanner (GE Medical Systems) with echo-planar capabil-
ities. Axial DWI were obtained using single-shot, spin
echo echoplanar imaging with the following parameters:
TR 5000 ms; TE 80 to 110 ms; b-value 1000 s/mm2;
field of view 22 cm; matrix size 128_128, zero-filled to
256_256, and slice thickness of 5 mm with a 1-mm in-
ter-slice gap. As many slices as needed to cover the en-
tire brain were acquired. For each slice a sequence
including an image without diffusion gradients plus
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acquired. This was repeated five times and resulted in 35
images for each slice and a total imaging time of less
than 4 minutes. Double inversion pulses were used to
help reduce eddy current effects.
The perfusion-weighted imaging (PWI) was a serial gradi-
ent echo echoplanar sequence with TR/TE of 1500/40 ms.
The field of view, section orientation, slice thickness, and
spacing were as specified previously in the DWI sequence.
Ten seconds after the beginning of image acquisition,
20 mL gadopentetate dimeglumine 0.5 mol/L (Magnevist;
Bayer HealthCare Pharmaceuticals) was injected at a rate of
5 mL/s followed by 20 mL normal saline at the same
rate. Sixteen slices were acquired every 1.5 seconds
and this was repeated 46 times, which resulted in
69 seconds of imaging time.
MRA images of the head were acquired using a three-
dimensional time-of-flight technique with 25° flip angle,
TR/TE of 36/6.8 ms, 18-cm field of view, and a 512 _ 512
matrix. One hundred eleven transverse images were
reconstructed with a section thickness of 1.4 mm and
spacing of 0.7 mm.
Image processing
In the retrospective study, the mean transit time (MTT)
map was calculated using singular value decomposition
deconvolution [9] with the arterial input function (AIF)
derived from the middle cerebral artery ipsilateral to the
infarct. This map was used as its clinical utility has been
demonstrated in multiple successful trials [10,11]. We
used the time to peak (TTP) map in the prospective
study because it is more commonly used. It has been
shown to have the highest predictive performance when
compared to standard MTT, circular MTT, and time to
maximum (Tmax) maps [6]. Image processing usually
consumes approximately 5 to 10 minutes; however exact
processing time was not available in our studies.
Post processing image analysis
In the retrospective study, lesions on DWI and MTT
maps were outlined visually by a research technologist
and were edited by a neuroradiologist (P.W.S.) using a
semi-automated commercially available image analysis
program (Analyze 7.0; AnalyzeDirect, Overland Park,
Kan). These were done blinded to time of stroke onset
and the locations of arterial occlusion. In the prospective
study, DWI abnormalities were outlined visually by a re-
search fellow and were checked by a neuroradiologist
(R.G.G.). After coregistration, PWI lesions were outlined
using a TTP delay threshold of greater than four seconds
relative to the contralateral hemisphere, which was found
to be the best estimate of penumbral tissue in a correlative
study of MRI and positron emission tomography [12].
The mean value of a region of interest covering the
contralateral MCA territory at the level of the basal gan-
glia was the reference for identifying tissue withTTP delay
beyond the 4 second threshold [12]. Perfusion map arti-
facts such as those arising within the ventricles were
excluded manually. Final outlines were checked by the
same neuroradiologist. All analyses were performed using
a semi-automated commercially available image analysis
program (Analyze 8.0; AnalyzeDirect, Overland Park,
Kan) and blinded to the clinical data of the patients and
the site of arterial occlusion.
The absolute volume of the diffusion-perfusion mis-
match was calculated as the difference between the re-
spective volumes. Areas of DWI abnormalities which
were not covered by PWI lesions were added to the total
perfusion abnormality volume for mismatch calculation.
A mismatch was considered zero if the PWI lesion was
smaller than the DWI lesion. Absolute mismatch volume
was divided by DWI lesion volume to yield relative mis-
match volume in percent, a value that has been used in
different clinical trials to recruit patients who may bene-
fit from thrombolytic therapies [10,11].
Statistical analysis
Patients with DWI lesions≤70 ml were compared to
those with lesions >70 ml for the likelihood of the pres-
ence of a 100% diffusion/perfusion mismatch using two-
tailed Fisher’s Exact Test. This analysis was repeated
using a DWI lesion volume threshold of 100 ml. Two-
tailed Spearman’s rank analyses were performed to as-
sess for a significant correlation between time from ictus
and DWI lesion volume, and between time from ictus
and relative mismatch values. A finding was deemed sig-
nificant if the P value was <0.05.
Results
Figures 1 and 2 illustrate the hypothesis that was tested.
In both cases, the patients underwent imaging that
included CTA followed by diffusion/perfusion MRI. Both
patients were found to have proximal anterior circula-
tion artery occlusion. However, one had a small DWI
lesion volume (Figure 1) at presentation, while the other
(Figure 2) had a very large DWI lesion volume. Our
hypothesis predicts that the patient with the small DWI
lesion will have a large diffusion/perfusion mismatch,
but not the patient with the large DWI abnormality. The
predictions were verified.
T h e r ew e r e6 8p a t i e n t si nt h er e t r o s p e c t i v es t u d y .
Figure 3 is a histogram that displays the DWI and
mismatch volumes of the entire cohort. There were
49 (72%) patients with volumes ≤70 ml and 19 (28%)
patients with volumes >70 ml. A mismatch of 100%
or greater was found in all 49 patients with DWI le-
sion volume ≤ 70 ml but in only 4 of 19 (21%)
patients with a larger DWI abnormality (p<0.0001)
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threshold of 100 ml, 96.4% (53/55) of patients had a
mismatch ≥100%. No patient with an abnormal DWI
volume >100 ml had a mismatch of 100% or greater
(p< 0.0001) (Figure 3).
In the prospective study, 55 consecutive patients were
identified. Seven cases were excluded from evaluation
because of poor quality of the perfusion data, motion
artifact, and in one case due to stenosis of a contralateral
anterior circulation proximal artery. The DWI and
Figure 1 61 year old male presenting with left facial droop and dysarthria. Initial imaging studies were performed 6 hours after witnessed
onset of speech difficulties. However, patient noted symptoms suggestive of facial weakness 12 hours prior to imaging. A & B. CTA demonstrates
a proximal right MCA occlusion (white arrows). C & D. Initial DWI shows multiple punctate foci of diffusion abnormality consistent with a small
acute infarct. E & F. Time to peak (TTP) MR perfusion map demonstrates a large volume of underperfused area involving the majority of the right
MCA territory and consequently a large diffusion/perfusion mismatch. The patient did not undergo thrombolytic therapy because of the
uncertain time between stroke onset and presentation. G & H. Follow-up MRI shows an infarction involving the majority of the right MCA
territory. Whole brain map volume measurements for this patient are: DWI: 2.1 ml; MTT: 117 ml (mismatch: 115.4 ml); TTP: 28 ml (mismatch
25.9 ml).
Figure 2 51 year old male presenting to the ED with right hemiparesis and aphasia. Imaging was initiated 4 hours after witnessed
symptom onset. A & B. CTA demonstrates occlusion of the proximal left MCA (white arrows). C & D. Initial DWI shows large abnormality of the
left MCA territory. E & F. MR perfusion time to peak (TTP) maps demonstrates hypoperfusion of similar extent as the diffusion abnormality. G & H.
Follow-up MRI shows no significant enlargement of the initial abnormality. Whole brain map volume measurements for this patient are: DWI:
154 ml; MTT: 211 ml (mismatch: 57 ml); TTP: 241 ml (mismatch 87 ml).
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shown in Figure 4. There were 35 (72.9%) patients with
DWI lesion volumes ≤70 ml, and all had DWI/PWI mis-
match ≥100%. Of 13 patients with DWI lesions >70 ml,
three (23%) had a mismatch ≥100% (p<0.0001) (Table 2).
Using the 100 ml abnormal DWI volume threshold,
97.4% (37/38) of patients with DWI lesion ≤100 ml
demonstrated a mismatch ≥100%, and all had a mis-
match ≥50%. Only 1 of the 10 cases with DWI lesion
>100 ml had a mismatch of 100% (p<0.0001) (Figure 4).
An analysis performed using MTT data for the prospect-
ive cohort had the same result as the analysis using TTP
maps (data not shown). Removal of the patients who
received IV tPA prior to imaging did not change the
results and all 24/32 patients with small DWI lesions
had a mismatch ≥100% (p<0.0001).
Individual patient imaging data and analysis of the
retrospective and prospective studies are provided in
Tables 3 and 4 respectively. The patient imaging data in
Figures 3 and 4 are displayed in order of time after
stroke onset. Analysis of the retrospective data set dis-
closed no significant correlation between time from ictus
and DWI lesion volume (p= 0.38) or between time and
mismatch volume (p=0.44). Similarly in the prospective
study, there was no significant correlation between time
from stroke onset and DWI volume (p=0.87) or between
time and mismatch volume (p=0.77). In both studies, all
patients with small DWI had large mismatches irrespect-
ive of their age or gender and there was no effect by these
covariates.
No significant difference was found between the
retrospective and prospective studies with respect to
DWI size and mismatch percentage. There is a signifi-
cant difference in mismatch volume (smaller in the
prospective study), likely due to difference in perfusion
analysis techniques. The main hypothesis is validated
in both groups.
Discussion
The occlusion of the terminal ICA and/or proximal
MCA accounts for the majority of deaths and poor out-
comes in patients with acute ischemic stroke [13,14].
Outcomes may be improved by treatment, but it is im-
portant to identify those who are most likely to benefit.
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Table 1 Demographic and imaging data of the retrospective cohort
All DWI lesion ≤70 ml DWI lesion >70 ml P value
Number (%) 68(100%) 49(72.1%) 19 (27.9%) 0.014
Age (median; IQR) 74.2; 27.7 74.2; 24.2 79.9; 42.3 0.554
Female 37 (54.4%) 27 (55.1%) 10 (52.6%) 0.930
DWI Vol. (median; IQR) 24.3; 72.6 12.4; 23.6 160.7; 126.7 0.000
Mismatch Vol. (median; IQR) 94.4; 91.5 99.2; 95.3 67.1; 103.3 0.007
% Mismatch (median; IQR) 347.9; 1534.4 1055.2; 1657.3 47.9; 84.9 0.113
Large mismatch (≥100%) 53 (77.9%) 49 (100%) 4 (21%) 0.000
DWI= diffusion weighted images; IQR= interquartile range.
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patients may be identified using physiological informa-
tion provided by imaging, specifically patients with a
major diffusion/perfusion mismatch [10,11]. We have
found in retrospective and prospective investigations
that every acute stroke patient with terminal ICA and/or
proximal MCA occlusion had a major (>100%) diffu-
sion/perfusion mismatch when the DWI lesion was
70 ml or less. If verified, our findings suggest a simple
alternative to perfusion imaging based solely on vessel
imaging and diffusion MRI to identify those patients
with major anterior circulation strokes that are most
likely to benefit from treatment.
The use of advanced neuroimaging to identify patients
most likely to benefit from therapy has been increasing
in recent years. Diffusion MRI is used to estimate the
core infarct, and perfusion-weighted imaging is used to
delineate hypoperfused tissue. The diffusion/perfusion
mismatch is considered the operational penumbra. This
approach has been successfully used in treating patients
with IV tPA (Tissue plasminogen activator) outside the
3 hour limit [15]. In the DEFUSE Trial [10], it was
shown that the use of tPA after 3 hours was effective if
there was a significant diffusion/perfusion mismatch that
included a DWI lesion of less than 100 ml. It has also
been used as inclusion criteria in successful phase 2
trials of desmoteplase, DIAS and DEDAS [10,11], in
which patients were given the drug outside the 3 hour
limit.
However, recent data including a meta-analysis of the
mismatch trials have raised questions regarding the ef-
fectiveness of the mismatch approach [2,16]. In parallel,
there has been increasing concern over the reliability of
perfusion imaging data [17]. Quantification of cerebral
hemodynamics is affected by numerous factors which
have not been standardized, including image acquisition,
Table 2 Demographic and imaging data of the prospective cohort
All DWI lesion ≤70 ml DWI lesion >70 ml P value
Number (%) 48 (100%) 35 (72.9%) 13 (27.1%) 0.035
Age
(median; IQR) 69.5; 22.3 69; 22.5 71; 20 0.688
Female 18 (37.5%) 16 (45.7%) 2 (15.4%) 0.092
DWI Vol.
(median; IQR) 19.2; 82.8 15.3; 16.8 129.6; 42.8 0.000
Mismatch Vol. (median; IQR) 51.6; 51.7 48.2; 44.1 83.9; 46.7 0.224
% Mismatch
(median; IQR) 214.5; 388.1 354.9; 436.7 56.7; 59.2 0.034
Large mismatch (≥100%) 38 (79.2%) 35 (100%) 3 (23.1%) 0.000
DWI= diffusion weighted images; IQR= interquartile range.
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Furthermore, one of the usual measures used, the per-
centage of mismatch, ignores the volume. A 5 ml infarct
and a 10 ml region of underperfusion would yield the
same percentage of mismatch as a 50 ml infarct and a
100 ml region of underperfusion. Additional problems
with perfusion methods include the time required for
data acquisition and processing, and the risks related to
further contrast administration. Most current approaches
for post-processing of the perfusion data require its trans-
fer to a dedicated workstation for further analysis, and a
trained individual to process it.
Our observation that a proximal anterior circulation
artery occlusion with a DWI lesion of 70 ml or less pre-
dicts a diffusion/perfusion mismatch of at least 100%
suggests a simple alternative to perfusion methods for
identifying major stroke patients most likely to benefit
from treatment. This observation is logical considering
the relevant physiology. Occlusion of the distal ICA and/
or the proximal MCA puts at risk a large brain region
Table 3 Individual patient imaging data of the
retrospective cohort arranged by time after stroke onset
Hours after
stroke
DWI
volume
MTT
volume
Mismatch
volume
Mismatch
%
1.4 1 85 83 7049
1.5 90 209 118 131
1.6 277 348 71 26
1.7 2 37 35 1508
1.9 85 148 63 75
2.0 150 290 140 93
2.0 72 168 96 134
2.0 161 228 67 42
2.0 170 14 0 0
2.0 0 49 49 52239
2.2 24 84 60 252
2.3 30 245 215 723
2.4 11 217 206 1898
2.5 17 170 152 871
2.8 252 484 232 92
2.9 232 289 57 25
3.0 17 174 157 912
3.3 7 126 120 1782
3.4 3 216 213 8290
3.4 5 86 81 1663
3.5 308 315 7 2
3.6 27 122 95 349
4.4 2 38 37 2249
4.4 43 128 86 201
4.4 65 204 139 216
4.4 8 177 169 2083
4.5 12 174 162 1321
4.6 29 128 99 347
4.8 115 170 55 48
4.9 0 68 68 49547
5.0 182 299 117 64
5.3 10 147 137 1439
5.6 2 53 51 2780
5.6 25 93 68 276
5.7 20 86 66 326
5.9 89 247 158 178
6.0 8 85 77 976
6.4 67 152 85 126
6.5 14 251 237 1667
6.6 166 283 117 70
6.7 1 140 138 12810
6.7 4 52 49 1356
6.8 11 257 246 2261
Table 3 Individual patient imaging data of the
retrospective cohort arranged by time after stroke onset
(Continued)
7.6 31 125 94 301
7.9 203 218 15 7
8.1 23 92 69 301
8.1 3 52 50 1983
8.2 44 180 136 313
9.0 23 317 295 1307
9.4 149 161 12 8
10.3 91 11 0 0
10.5 65 272 207 319
11.0 58 248 191 330
11.2 232 181 0 0
11.2 18 75 93 513
12.7 12 203 190 1529
13.0 3 87 84 2475
14.0 60 176 116 195
15.2 26 206 180 691
15.8 9 166 158 1818
16.8 19 216 198 1055
17.4 3 14 11 406
18.0 6 191 186 3234
19.5 62 157 95 153
21.1 79 167 87 110
21.2 1 123 122 12052
22.3 50 127 77 153
22.7 11 85 74 658
All volumes are in ml; DWI= diffusion weighted images.
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brain at the time of evaluation depends on the vigour of
the collateral flow, which determines the sizes of the in-
farct core and penumbra reflected in the diffusion/perfu-
sion mismatch. The collateral flow that arises after ICA/
MCA occlusion makes the core and penumbra inter-
dependent parameters [19,20]. Excellent collateral flow
accompanying a major occlusion will result in a small
diffusion abnormality and a large mismatch (Figure 1),
with the opposite result in the setting of poor collateral
flow (Figure 2).
We are not advocating a 100% mismatch for clinical
decisions, only that in this subset of patients a large mis-
match (definitely >20% and usually much larger) is al-
most certainly present and clinicians can reliably use
this information to manage patients.
Our choice of the diffusion abnormality volume
threshold of 70 ml was based on previous observations
that patients with anterior circulation occlusions and dif-
fusion abnormalities larger than 70 ml have poor
outcomes regardless of treatment [21-24], including suc-
cessful endovascular recanalization [19]. Patients with
small diffusion abnormalities had good outcomes only if
the occluded arteries were promptly recanalized [19].
There may be a more optimal DWI threshold, and this
is an area that merits further study. The measurement of
the abnormal DWI volume can be performed manually
or semi-automatically using a variety of software. Alter-
natively, it has been demonstrated that DWI or PWI le-
sion volumes can be reliably approximated using the
formula ABC/2, where A, B, and C are the longest 3 or-
thogonal distances of the lesion as measured on the MR
console or PACS workstation [25,26].
It should be emphasized that the method proposed
here is restricted to the specific condition of patients
with distal ICA and/or mainstem MCA occlusions. Per-
fusion imaging may remain beneficial and superior in
situations where there are occlusions of anterior circula-
tion branch arteries, proximal ICA, and posterior circu-
lation strokes. It is also probable that perfusion imaging
will be of benefit in those without an identifiable occlu-
sion, and in many situations in which a TIA is in the dif-
ferential diagnosis.
Table 4 Individual patient imaging data of the
prospective cohort arranged by time after stroke onset
Hours after
stroke
DWI
volume
TTP
volume
Mismatch
volume
Mismatch
%
0.5 11 57 46 417
1.6 3 18 20 649
1.7 18 106 88 502
2.5 16 52 36 229
2.7 99 208 109 109
3.0 88 186 97 110
3.0 17 37 21 121
3.1 60 180 120 200
4.1 23 54 31 132
4.2 69 250 181 263
4.5 8 206 199 2556
4.5 15 92 76 497
4.7 0 3 3 615
4.7 34 82 48 142
4.8 154 242 88 57
5.0 121 205 84 69
5.0 116 151 36 31
5.1 8 19 10 120
5.2 118 260 143 121
5.2 158 200 41 26
5.3 7 26 18 254
5.3 24 50 26 110
5.5 18 68 50 277
5.5 20 93 73 367
5.7 11 59 49 460
5.7 101 153 53 52
5.7 244 286 42 17
5.9 12 84 72 578
5.9 13 35 22 177
6.1 5 30 25 491
6.2 1 37 37 5883
6.2 2 66 64 3490
6.2 29 84 56 195
6.3 192 270 78 41
6.4 8 145 138 1832
6.5 18 82 64 347
6.6 4 51 47 1261
6.6 304 354 51 17
6.6 37 160 123 332
6.6 39 178 139 355
7.7 43 105 63 148
9.0 16 49 32 196
10.8 150 243 93 62
Table 4 Individual patient imaging data of the
prospective cohort arranged by time after stroke onset
(Continued)
12.3 58 129 72 125
12.7 2 43 41 1719
12.8 2 28 26 1211
13.4 130 246 117 90
14.4 6 49 43 684
All volumes are in ml; DWI= diffusion weighted images.
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Patients with acute terminal ICA and/or proximal MCA
occlusion will have a diffusion/perfusion mismatch at
least as large as the DWI abnormality if the DWI lesion
volume is 70 ml or less. Thus, identification of such an
occlusion, easily made by CT or MR angiography, and
the finding of an abnormal DWI volume of less than
70 ml can identify patients most likely to benefit from
an intervention as effectively and more simply than
identifying a diffusion/perfusion mismatch as is cur-
rently practiced.
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